Literature DB >> 9037715

The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes.

J Grötzinger1, G Kurapkat, A Wollmer, M Kalai, S Rose-John.   

Abstract

The cytokines IL-6, LIF, CNTF, OSM, IL-11, and CT-1 have been grouped into the family of IL-6-type cytokines, since they all require gp130 for signal transduction. Interestingly, gp130 binds directly to OSM, whereas complex formation with the other cytokines depends on additional receptor subunits. Only limited structural information on these cytokines and their receptors is available. X-ray structures have been solved for the cytokines LIF and CNTF, whose up-up-down-down four-helix bundle is common to all of these cytokines, and for the receptors of hGH and prolactin, which contain two domains with a fibronectin III-like fold. Since cocrystallization and x-ray analysis of the up to four different proteins forming the receptor complexes of the IL-6-type cytokines is unlikely to be achieved in the near future, model building based on the existing structural information is the only approach for the time being. Here we present model structures of the complexes of human and murine IL-6 with their receptors. Their validity can be deduced from the fact that published mutagenesis data and the different receptor specificity of human and murine IL-6 can be understood. It is now possible to predict the relative positions and contacts for all molecules in their respective complexes. Such information can be used for the rational design of cytokine and receptor antagonists, which may have a valuable therapeutic perspective.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037715

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  25 in total

Review 1.  Molecular mechanisms regulating motor neuron development and degeneration.

Authors:  T J Kilpatrick; M Soilu-Hänninen
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region.

Authors:  T Kernebeck; S Pflanz; G Müller-Newen; G Kurapkat; R M Scheek; K Dijkstra; P C Heinrich; A Wollmer; S Grzesiek; J Grötzinger
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

Review 3.  Cytokine homologs of human gammaherpesviruses.

Authors:  Sang-Hoon Sin; Dirk P Dittmer
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

Review 4.  Bioengineered nerve regeneration and muscle reinnervation.

Authors:  Paul J Kingham; Giorgio Terenghi
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

5.  Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.

Authors:  H Dahmen; U Horsten; A Küster; Y Jacques; S Minvielle; I M Kerr; G Ciliberto; G Paonessa; P C Heinrich; G Müller-Newen
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

6.  IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages.

Authors:  Poonam Kothari; Roberto Pestana; Rim Mesraoua; Rim Elchaki; K M Faisal Khan; Andrew J Dannenberg; Domenick J Falcone
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

Review 7.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

8.  The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR).

Authors:  Eva-Maria Wagener; Matthias Aurich; Samadhi Aparicio-Siegmund; Doreen M Floss; Christoph Garbers; Kati Breusing; Björn Rabe; Ralf Schwanbeck; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

9.  Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.

Authors:  P Schirmacher; M Peters; G Ciliberto; M Blessing; J Lotz; K H Meyer zum Büschenfelde; S Rose-John
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

10.  Characterization of a potent human interleukin-11 agonist.

Authors:  Dimitri Harmegnies; Xiao-Ming Wang; Paul Vandenbussche; Arnaud Leon; Patricia Vusio; Joachim Grötzinger; Yannick Jacques; Erik Goormaghtigh; Bart Devreese; Jean Content
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.